- Waller deemed competent to stand trial (1/11/17)5
- Young Elvis impersonator from Bernie performs on 'Ellen DeGeneres Show' (1/12/17)
- 113 drug tests at Jackson High net one instance of illicit usage (1/11/17)14
- Two subjects of interest in 1992 homicide to take polygraph tests (1/15/17)6
- Two men shot after argument; houses also struck by bullets (1/12/17)21
- Imo's Pizza will be added to Rhodes 101 convenience store in Jackson (1/10/17)16
- Cape SportsPlex contractor offers a look at the project (1/15/17)13
- Juvenile accused of stealing, damaging playground statue (1/9/17)25
- Two Cape men recovering after shooting (1/13/17)
- Business notebook: Faithfully Fed aims for more than just food (1/9/17)4
TB awareness, vaccine research
Thank you for writing about the difficulties of controlling tuberculosis and the need for concern regarding TB in the U.S. ("Tuberculosis not just a Third World disease," March 30).
Unfortunately like most infectious diseases, TB knows no borders, and truly TB anywhere. Worldwide, there are 1.8 million deaths from TB and an estimated 9.3 million new cases of TB a year. These overwhelming numbers are in spite of the vaccine against tuberculosis mentioned in the article, called BCG, which is about 90 years old. Despite widespread use in most of the world, BCG vaccination has not been effective in protecting against pulmonary TB in adults, the most common form of the disease and the cause of TB spreading from person to person.
Today scientists around the world are searching for new and better TB vaccines. In fact, our organization is working with researchers at St. Louis University who are playing an important role in the clinical testing of several promising TB vaccine candidates. We hope to see new, effective vaccines available in the next decade to help control the global TB epidemic. However, to truly eliminate TB as a public health threat, greater awareness and political will is needed at all national and international levels to lead a comprehensive fight against TB with better control efforts and a greater investment in new tools for the future.
Dr. LEWELLYS F. BARKER, Aeras Global TB Vaccine Foundation, Rockville, Md.